New York, United States, March 06, 2025 (GLOBE NEWSWIRE) — Irritable bowel syndrome is a digestive disorder characterized by altered bowel patterns and abdominal discomfort. IBS is shortened to IBS. IBS-D is an alternative term for irritable bowel syndrome. It inhibits the normal mobility of the intestinal tract’s muscle linings, slowing food movement through the digestive tract. The severity of an individual’s irritable bowel syndrome symptoms can determine whether they have the moderate or severe subtype of the condition. These symptoms include abdominal cramping, discomfort, bloating, flatulence, mucus in the stool, constipation, and diarrhea. Additionally, you may experience bloating and flatulence.
However, the precise cause of irritable bowel syndrome is unknown. Irritable bowel syndrome is characterized by heightened awareness of one’s physiological functions as well as abnormal motions of the gastrointestinal tract. Endoscopic procedures, blood tests, stool testing, and external imaging studies can diagnose irritable bowel syndrome (IBS).
Download Free Sample Report PDF @ https://straitsresearch.com/report/irritable-bowel-syndrome-treatment-market/request-sample
Market Dynamics
Rise in Geriatric Population Drives the Global Market
The percentage of elderly adults in the global population is rapidly increasing. Treatments for irritable bowel syndrome are in greater demand because older individuals are more likely to develop serious gastrointestinal disorders, which drives up demand. In addition, other age-related changes, such as the inability to consume meals, inadequate hydration consumption, and diverticular disease, damage the gastrointestinal tract (GT) system, which drives the demand for irritable bowel syndrome treatment.
Consequently, the increasing global prevalence of chronic diseases greatly burdens global healthcare systems. This is a direct consequence of the global increase in the elderly population. Consequently, it is anticipated that an increase in the global population of individuals aged 65 and older will fuel the demand for IBS treatments.
Untapped Opportunities in Developing Economies Creates Tremendous Opportunities
Emerging economies have a substantial capacity for future growth due to the availability of improved healthcare infrastructure, unmet healthcare demands, and a rise in the incidence of cardiovascular diseases. In addition, developing nations such as China and India present lucrative opportunities for the market’s leading participants in treating irritable bowel syndrome. This is due to a large population base, increased awareness regarding treatments for irritable bowel syndrome, and …
